Company Overview
- Headquarters
- 1616 Eastlake Ave E, Ste 300, Seattle WA
- Website
- cajalneuro.com
- Employees
- 58
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Cajal Neuroscience
Cajal Neuroscience, headquartered in Seattle, Washington, is a drug discovery company specializing in neurodegenerative diseases. The company employs 58 individuals and generates annual revenue of $50 million. Cajal Neuroscience focuses on developing innovative therapies to address the challenges posed by neurodegenerative diseases. Their research efforts aim to advance understanding and provide effective treatments for these complex conditions. Driven by scientific rigor and a commitment to improving patient lives, Cajal Neuroscience leverages cutting-edge technology and expertise in neuroscience to advance drug discovery. Visit cajalneuro.com to learn more.
Company Leadership
Cajal Neuroscience Industry Tags
Companies Similar to Cajal Neuroscience
Analyze industry trends and opportunities by examining competitors and companies comparable to Cajal Neuroscience, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |